A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
The Lancet. Infectious diseases - 22(2022), 6 vom: 16. Juni, Seite 767-768 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lorthe, Elsa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 03.06.2022 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/S1473-3099(22)00267-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM339594365 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM339594365 | ||
| 003 | DE-627 | ||
| 005 | 20231226003238.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1473-3099(22)00267-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1131.xml |
| 035 | |a (DE-627)NLM339594365 | ||
| 035 | |a (NLM)35429994 | ||
| 035 | |a (PII)S1473-3099(22)00267-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lorthe, Elsa |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.06.2022 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Bellon, Mathilde |e verfasserin |4 aut | |
| 700 | 1 | |a Berthelot, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Michielin, Grégoire |e verfasserin |4 aut | |
| 700 | 1 | |a L'Huillier, Arnaud G |e verfasserin |4 aut | |
| 700 | 1 | |a Posfay-Barbe, Klara M |e verfasserin |4 aut | |
| 700 | 1 | |a Azman, Andrew S |e verfasserin |4 aut | |
| 700 | 1 | |a Guessous, Idris |e verfasserin |4 aut | |
| 700 | 1 | |a Maerkl, Sebastian J |e verfasserin |4 aut | |
| 700 | 1 | |a Eckerle, Isabella |e verfasserin |4 aut | |
| 700 | 1 | |a Stringhini, Silvia |e verfasserin |4 aut | |
| 700 | 0 | |a SEROCoV-Schools Study Group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Infectious diseases |d 2001 |g 22(2022), 6 vom: 16. Juni, Seite 767-768 |w (DE-627)NLM117564362 |x 1474-4457 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g number:6 |g day:16 |g month:06 |g pages:767-768 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1473-3099(22)00267-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |e 6 |b 16 |c 06 |h 767-768 | ||